Clinical Trial Update: A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 [Phase 1]

View source ↗

Summary

A Phase I trial studying infusional chemotherapy with the P-glycoprotein antagonist PSC 833 has been completed in patients with several cancers, including breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer
• Kidney Cancer
• Lymphoma
• Ovarian Cancer

Drugs mentioned

• PSC 833 (valspodar)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Kidney Neoplasm | Phase 1 | Status: COMPLETED